FDA approves Abeona’s skin disease cell therapynews2025-04-29T15:06:37+00:00April 29th, 2025|Endpoints News|
RFK Jr. touts program testing ways to pay for sickle cell carenews2025-04-25T17:12:04+00:00April 25th, 2025|Endpoints News|
Caribou lays off 32% of staff, cuts lupus programnews2025-04-24T20:15:36+00:00April 24th, 2025|Endpoints News|
Ayrmid misses deadline for detailed offer to top private equity bid for bluebirdnews2025-04-16T13:48:58+00:00April 16th, 2025|Endpoints News|
Cell therapy startup Myeloid narrows focus as staff shrinksnews2025-04-15T01:38:14+00:00April 15th, 2025|Endpoints News|
Verve unveils early data from second attempt at heart disease gene editingnews2025-04-14T11:00:35+00:00April 14th, 2025|Endpoints News|
Cell and gene therapy CDMO AmplifyBio shuts down over ‘scarcity’ of fundingnews2025-04-07T10:26:49+00:00April 7th, 2025|Endpoints News|
Exclusive: Neurona bags $102M to treat epilepsy with cell therapynews2025-04-03T10:00:15+00:00April 3rd, 2025|Endpoints News|
Biopharma execs rethink Trump impact after FDA cutsnews2025-04-02T19:47:10+00:00April 2nd, 2025|Endpoints News|
Atsena raises $150M to target rare form of blindness with gene therapynews2025-04-02T11:30:59+00:00April 2nd, 2025|Endpoints News|
